techcentury.com
Millendo Starts Phase 2 Trial Of New Drug For Cushing’s Syndrome
ANN ARBOR — The Ann Arbor pharmaceutical developer Millendo Therapeutics Inc. has announced the initiation of a Phase 2 clinical trial evaluating the safety and efficacy of its drug candidate…